Home » Topics » Medical technology

Medical technology
RSS

IPOS: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY AFTER-MARKET PERFORMANCE

Jan. 28, 2008

Nuvelo Still Seeking Efficacy of Thrombolytic Drug Alfimeprase

Jan. 28, 2008

By Jennifer Boggs

Financings roundup: IPC prices IPO to raise $83M; MicroIslet borrowing $1 million

Jan. 28, 2008

Cook launches trial for ‘first of its kind’ for aortic dissection

Jan. 28, 2008

PERFORMANCE ON ALL PUBLIC OFFERINGS: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS

Jan. 28, 2008

Clinic Roundup

Jan. 28, 2008

Agreements: AxoGen, Stryker in distribution pact for Avance Nerve Graft

Jan. 28, 2008

Public Citizen seeks stronger warnings for Botox and Myobloc

Jan. 28, 2008

By Holland Johnson

UNDERWRITERS' PERFORMANCE ON IPOS: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS

Jan. 28, 2008

U.S. Public Offering Performance By Underwriter: January 1 December 31, 2007

Jan. 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...